Lucas Nivon

Form D signer

Lucas Nivon

Chief Executive Officer at Cyrus Biotechnology

Form D signer

Capital raised by Cyrus Biotechnology

$1.5M+$1.5M latest round

1 Form D filing · first filed Jul 2025 · Seattle, WA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

Cyrus BiotechnologyBiotech · Seattle, WAsince Jul 2025

Chief Executive Officer

Signatory on Cyrus Biotechnology's Form D filings · $1.5M raised across 1

Company filings

via EDGAR · Form D for Cyrus Biotechnology1

DateCompanyFormAmountRole on filing

Jul 1, 2025Cyrus BiotechnologyForm D/A+$1.5MChief Executive Officer

Form D/AJul 1, 2025 · Cyrus Biotechnology+$1.5Mas Chief Executive Officer

Overview

Last filing Jul 1, 2025

Lucas Nivon is on file as Chief Executive Officer at Cyrus Biotechnology in Seattle, WA. Cyrus Biotechnology has 1 Form D filing on record, $1.5M raised in total. Lucas Nivon appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Cyrus Biotechnology · 1

Jason SmithDirector

Products

Cyrus Biotechnology · 1

Cyrus protein design platformComputational drug discovery platform

A computational protein engineering platform that pairs novel algorithms with laboratory deep mutagenesis to redesign naturally occurring proteins into drug candidates, built on the Rosetta molecular modeling toolkit and commercialized to biopharma as Cyrus Bench.